1
|
Villegas-Becerril E, Jimenez-Garcia C, Perula-de Torres L, Espinosa-Calvo M, Bueno-Serrano C, Romero-Ruperto F, Gines-Santiago F, Moreno-Manzanaro M, Muñoz-Gavilan J, Montes-Redondo G, Quesada-Roman M, Linares-Ramirez M, Parras-Rejano J, Muñoz-Alcaraz N, Maestre-Serrano M, Romero-Rodriguez E. Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients (the Alantel study). Contemp Clin Trials Commun 2024; 39:101288. [PMID: 38616815 PMCID: PMC11010796 DOI: 10.1016/j.conctc.2024.101288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Revised: 02/27/2024] [Accepted: 03/26/2024] [Indexed: 04/16/2024] Open
Abstract
Objectives Radiation-induced dermatitis (RD) is one of the most common toxicities in radiation therapy (RT) patients. Corticosteroids, immunosuppressants, and natural products (NPs) have been used as treatment. The objective was to evaluate the efficacy of a NPs-based cream (Alantel®) to reduce the incidence of RD in women with breast cancer undergoing RT treatment. Design We conducted a controlled, randomized, double-blind clinical trial. Setting Radiation Oncology Unit of the Reina Sofía Hospital and 5 Primary Care centers of the Cordoba and Guadalquivir Health District (Spain). Interventions Patients assigned to the experimental group (GTA) were treated with Alantel, while those in the control group (GTE) were treated with a moisturizer and emollient cream. Main outcome measures The primary outcome variable was the incidence of RD. RD-free time, duration of RD, quality of life, and product safety were also assessed. Results Seventy patients were included in the study, 35 in the GTA and 35 in the GTE. The incidence of RD was lower in the GTA (71.4%) than in the GTE (91.4%) after 4 weeks of follow-up (RR = 0.78; NNT = 5; p < 0.031). The Skindex-29 questionnaire showed differences in the statement: "My skin condition makes it hard to work or do hobbies" (17.1% in the GTE vs. 2.9% in GTA; p = 0.024). Conclusions The higher efficacy of Alantel® compared to the control cream in reducing the incidence of RD in women with breast cancer has been demonstrated.
Collapse
Affiliation(s)
- E. Villegas-Becerril
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Maser Clinic, Cordoba, Spain
| | - C. Jimenez-Garcia
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Epidemiology Service, Cordoba-Guadalquivir Health District, 14011 Cordoba, Spain
| | - L.A. Perula-de Torres
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Research Network on Chronicity, Primary Care and Prevention and Health Promotion RICAPS-ISCIII, Cordoba, Spain
| | - M. Espinosa-Calvo
- Radiotherapy Oncology Service. Reina Sofia University Hospital, Cordoba, Spain
| | - C.M. Bueno-Serrano
- Radiotherapy Oncology Service. Reina Sofia University Hospital, Cordoba, Spain
| | - F. Romero-Ruperto
- Radiotherapy Oncology Service. Reina Sofia University Hospital, Cordoba, Spain
| | - F. Gines-Santiago
- Radiotherapy Oncology Service. Reina Sofia University Hospital, Cordoba, Spain
| | | | - J.J. Muñoz-Gavilan
- Lucano Clinical Management Unit, Cordoba-Guadalquivir Health District, Cordoba, Spain
| | - G. Montes-Redondo
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Cordoba-Guadalquivir Health District, Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain
- Santa Rosa Clinical Management Unit, Cordoba-Guadalquivir Health District, Cordoba, Spain
| | - M.A. Quesada-Roman
- Lucano Clinical Management Unit, Cordoba-Guadalquivir Health District, Cordoba, Spain
| | - M.C. Linares-Ramirez
- Santa Rosa Clinical Management Unit, Cordoba-Guadalquivir Health District, Cordoba, Spain
| | - J.M. Parras-Rejano
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Huerta de la Reina Clinical Management Unit, Cordoba-Guadalquivir Health District, Maimonides Institute for Biomedical Research IMIBIC, Cordoba, Spain
| | - N. Muñoz-Alcaraz
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Support System of the Cordoba-Guadalquivir Health District, Maimonides Institute for Biomedical Research IMIBIC, Cordoba, Spain
| | - M.D. Maestre-Serrano
- Lucano Clinical Management Unit, Cordoba-Guadalquivir Health District, Cordoba, Spain
| | - E.M. Romero-Rodriguez
- Maimonides Institute for Biomedical Research IMIBIC, Cordoba University, 14004, Cordoba, Spain
- Cordoba-Guadalquivir Health District, Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain
| |
Collapse
|
2
|
Noli C, Morelli G, della Valle MF, Schievano C. Effects of a Protocol Combining a Non-Irritating Shampoo and an Adelmidrol-Based Adsorbent Mousse on Seborrhoea and Other Signs and Symptoms Secondary to Canine Atopic Dermatitis: A Multicenter, Open-Label Uncontrolled Clinical Trial. Vet Sci 2024; 11:229. [PMID: 38921976 PMCID: PMC11209480 DOI: 10.3390/vetsci11060229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2024] [Revised: 05/13/2024] [Accepted: 05/16/2024] [Indexed: 06/27/2024] Open
Abstract
The present study aimed at evaluating the effect of a gentle shampoo and a mousse containing Adelmidrol, tapioca starch and a non-prescription antimicrobial complex on seborrhoea and other clinical signs secondary to canine atopic dermatitis (cAD). Forty-six dogs with cAD-associated seborrhoea and/or pruritus > 4 cm on the pruritus visual analogue scale (P-VAS) and/or bacterial/Malassezia overgrowth were enrolled. The mousse was applied twice daily, and dogs were evaluated at days (D)0, 7, 14 and optionally 28, by means of a skin seborrheic index (SSI), P-VAS, cAD lesion index (CADLI), and a semiquantitative cytological score. The mean SSI value improved during the first two weeks (4.1 ± 0.37 to 1.9 ± 0.30; p < 0.0001). The mean P-VAS score (cm) decreased from 6.6 ± 0.19 at D0 to 3.8 ± 0.31 at D14 (p < 0.0001). The mean CADLI score dropped from 13.7 ± 1.24 to 8.5 ± 1.14 at D14 (p < 0.001). The cytological score for bacteria and Malassezia decreased from 3.2 ± 0.10 and 3.2 ± 0.11, respectively, to 1.2 ± 0.19 and 1.2 ± 0.24 (p < 0.0001). All the investigated signs further improved at D28. Altogether, these observations suggest that the tested protocol might be useful in managing cAD-associated signs.
Collapse
Affiliation(s)
- Chiara Noli
- Servizi Dermatologici Veterinari, Strada Bedale della Ressia 2, 12016 Peveragno, Italy
| | - Giada Morelli
- CeDIS (Science Information and Documentation Center), Innovet Italia Srl, Via Leonardo Da Vinci 3, 35030 Saccolongo, Italy
| | - Maria Federica della Valle
- CeDIS (Science Information and Documentation Center), Innovet Italia Srl, Via Leonardo Da Vinci 3, 35030 Saccolongo, Italy
| | - Carlo Schievano
- Innovative Statistical Research Srl, Prato della Valle 24, 35123 Padova, Italy
| | | |
Collapse
|
3
|
Belkhelladi M, Bougrine A. Rosehip extract and wound healing: A review. J Cosmet Dermatol 2024; 23:62-67. [PMID: 37605366 DOI: 10.1111/jocd.15971] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 07/25/2023] [Accepted: 08/13/2023] [Indexed: 08/23/2023]
Abstract
BACKGROUND Each year, over 100 million patients are afflicted with new scars from medical procedures worldwide. Natural compounds have shown promise in the treatment of scars and skin disorders. Rosehip oil (RO), produced from the pressed fruit of the rosehip (Rosa canina L.) plant, is used in the pharmaceutical, cosmetic, and food industries. The use of this plant in the treatment of scars has yet to be reviewed. AIMS This review aims to analyze the current findings on the use of RO in the treatment of postsurgical scars. METHODS This literature search considered published journal articles (clinical trials or literature reviews). Studies were identified by searching electronic databases (PubMed and MEDLINE) and reference lists of respective articles. Additional articles were identified through Google Scholar. Only articles available in English were included in this review. RESULTS There is a scarcity of high-quality studies assessing the therapeutic potential of RO. From the two human clinical trials using RO, there is some evidence to suggest its potential as an active ingredient in topical formulations for the treatment of wounds. Topical treatments containing RO extract may reduce the size and erythema of postsurgical scars through the polarization of macrophages and the inhibition of inflammatory cytokines. CONCLUSIONS Some evidence suggests that RO may improve postsurgical scars. At present, there is insufficient evidence to recommend the use of RO for the treatment of wounds. Further investigation is required to establish its therapeutic effects on human skin and its potential use as an ingredient in topical formulations.
Collapse
|
4
|
Mansoor K, Aburjai T, Al-Mamoori F, Schmidt M. Plants with cosmetic uses. Phytother Res 2023; 37:5755-5768. [PMID: 37770185 DOI: 10.1002/ptr.8019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Revised: 08/16/2023] [Accepted: 09/11/2023] [Indexed: 10/03/2023]
Abstract
The use of plants as a source of active principles for cosmetics has significantly increased in the last few years. Safety, compatibility with all types of skin, fewer side effects, and availability are among the advantages of herbal cosmetics above synthetic ingredients. The present review aims to explore the most important plants used in cosmetics. A literature search was carried out in several electronic databases with the following phrases: skincare and plants; cosmetics and plants; natural and cosmetics; and natural and skincare. Furthermore, more detailed filters such as clinical studies, meta-analyses, and systemic reviews were applied to positive results. Various plants and plant extracts currently used in skin care, scaring, whitening, and aging, as well as in sun protection, acne, eczema, and others, have been included in this review. The effectiveness of these plants is based mainly on preclinical research, and to a lesser extent on clinical studies. Some plant extracts or oils have been tested clinically, such as onions, aloe, and tea tree oil, more than other plant extracts. Despite many studies on natural products to improve dermal needs, proper clinical cosmeceutical trials are much fewer than expected. Therefore, more clinical trials are needed to evaluate appropriate efficacy. Furthermore, new formulation technologies might enhance the cosmeceutical benefits, but more work is warranted.
Collapse
Affiliation(s)
- Kenza Mansoor
- Department of Pharmaceutical Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan
| | - Talal Aburjai
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman, Jordan
| | - Farah Al-Mamoori
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Zarqa, Jordan
| | | |
Collapse
|